Company Filing History:
2 out of 2,893 
2 out of 444 
1 out of 601 
Years Active: 2023-2025
Title: Gad Getz: Innovator in Cancer Immunotherapy
Introduction
Gad Getz is a prominent inventor based in Boston, MA, known for his significant contributions to the field of cancer immunotherapy. With a focus on tumor infiltrating lymphocytes and their role in immunotherapy, Getz has developed innovative methods and compositions that enhance the understanding and treatment of cancer.
Latest Patents
Gad Getz holds 2 patents, with his latest inventions focusing on critical advancements in cancer treatment. One of his notable patents is titled "Methods and compositions of use of CD8+ tumor infiltrating lymphocyte subtypes and gene signatures thereof." This invention is directed towards CD8+ tumor infiltrating lymphocytes that comprise gene signatures associated with responses to immunotherapy treatment. The patent outlines methods and compositions for utilizing these gene signatures, particularly in relation to checkpoint blockade therapy and immune cell subtypes characterized by these signatures. Additionally, it includes pharmaceutical compositions that comprise populations of CD8+ TILs enriched for specific subtypes.
Another significant patent by Getz is centered on "Methods for characterizing bladder cancer." This invention features methods for characterizing mutational profiles in patients diagnosed with bladder cancer, providing valuable insights into personalized treatment approaches.
Career Highlights
Throughout his career, Gad Getz has worked with esteemed organizations such as the General Hospital Corporation and the Broad Institute, Inc. His work in these institutions has allowed him to collaborate with leading experts in the field and contribute to groundbreaking research in cancer treatment.
Collaborations
Gad Getz has collaborated with notable colleagues, including Moshe Sade-Feldman and Keren Yizhak. These partnerships have further enriched his research and innovations in cancer immunotherapy.
Conclusion
Gad Getz's contributions to cancer immunotherapy through his patents and collaborations highlight his role as a leading innovator in the field. His work continues to pave the way for advancements in cancer treatment and patient care.